A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B ...

A collaborative investigation among experts in Alzheimer's disease and multiple sclerosis (MS) finds evidence that MS patients are less likely to have amyloid plaques, a hallmark of Alzheimer's ...

Initiating high-efficacy monoclonal antibody therapy before age 18 may reduce long-term disability in pediatric-onset multiple sclerosis.

Growing skin plaques with scale Increased incidence may be related to interferon beta exposure during treatment for multiple sclerosis. Patients with multiple sclerosis (MS) have a high rate of ...

Difficulties finding the right words during speech affect 25% of MS patients, and often occur alongside broader cognitive ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Multiple sclerosis is a chronic autoimmune disorder that affects the central nervous system, causing episodes of neurologic dysfunction and often gradual disease progression. The immune system ...

The latest PBS stoush with drugmakers means thousands of people with MS are at risk of being forced to pay $33,000 a year for ...

Registry-linked gross income trajectories (wages, capital gains, transfers) showed lower long-term income growth in 1,071 MS cases versus 15,493 matched controls, with 72% women in the cohort.

“This study found that having bladder problems was significantly associated with lower well-being in [people with] MS, particularly when considering OAB. Bowel problems, self-management of bladder ...